Similar articles for PMID: 18436612

Year	Number of Results
1995	2
1997	1
1998	1
2000	2
2001	1
2002	5
2003	4
2004	5
2005	8
2006	8
2007	10
2008	9
2009	3
2010	6
2011	5
2012	4
2013	6
2014	2
2015	4
2016	6
2017	5
2018	3
2019	1
2020	2
2021	1

1

Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects?

Moon WJ, Kim HJ, Roh HG, Han SH. Moon WJ, et al. AJNR Am J Neuroradiol. 2008 Aug;29(7):1308-13. doi: 10.3174/ajnr.A1103. Epub 2008 Apr 24. AJNR Am J Neuroradiol. 2008. PMID: 18436612 Free PMC article.

2

MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Hanyu H, Asano T, Sakurai H, Tanaka Y, Takasaki M, Abe K. Hanyu H, et al. AJNR Am J Neuroradiol. 2002 Jan;23(1):27-32. AJNR Am J Neuroradiol. 2002. PMID: 11827872 Free PMC article.

3

MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.

Sasaki M, Ehara S, Tamakawa Y, Takahashi S, Tohgi H, Sakai A, Mita T. Sasaki M, et al. AJNR Am J Neuroradiol. 1995 Nov-Dec;16(10):2001-7. AJNR Am J Neuroradiol. 1995. PMID: 8585486 Free PMC article.

4

Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.

Kim HJ, Moon WJ, Han SH. Kim HJ, et al. J Alzheimers Dis. 2013;35(1):129-36. doi: 10.3233/JAD-122320. J Alzheimers Dis. 2013. PMID: 23364137

5

MR features of the substantia innominata and therapeutic implications in dementias.

Hanyu H, Shimizu S, Tanaka Y, Hirao K, Iwamoto T, Abe K. Hanyu H, et al. Neurobiol Aging. 2007 Apr;28(4):548-54. doi: 10.1016/j.neurobiolaging.2006.02.009. Epub 2006 Mar 29. Neurobiol Aging. 2007. PMID: 16569466 Clinical Trial.

6

Substantia innominata: MR findings in Parkinson's disease.

Oikawa H, Sasaki M, Ehara S, Abe T. Oikawa H, et al. Neuroradiology. 2004 Oct;46(10):817-21. doi: 10.1007/s00234-004-1257-4. Neuroradiology. 2004. PMID: 15316699

7

Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients.

Tanaka Y, Hanyu H, Sakurai H, Takasaki M, Abe K. Tanaka Y, et al. Dement Geriatr Cogn Disord. 2003;16(3):119-25. doi: 10.1159/000070998. Dement Geriatr Cogn Disord. 2003. PMID: 12826736

8

Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.

Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC. Barnes J, et al. Arch Neurol. 2006 Oct;63(10):1434-9. doi: 10.1001/archneur.63.10.1434. Arch Neurol. 2006. PMID: 17030660

9

Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease.

Hanyu H, Tanaka Y, Sakurai H, Takasaki M, Abe K. Hanyu H, et al. Neurosci Lett. 2002 Feb 8;319(1):33-6. doi: 10.1016/s0304-3940(01)02507-1. Neurosci Lett. 2002. PMID: 11814647 Clinical Trial.

10

Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls.

Looi JC, Svensson L, Lindberg O, Zandbelt BB, Ostberg P, Orndahl E, Wahlund LO. Looi JC, et al. AJNR Am J Neuroradiol. 2009 Sep;30(8):1552-60. doi: 10.3174/ajnr.A1640. Epub 2009 Jun 4. AJNR Am J Neuroradiol. 2009. PMID: 19497964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed